AstraZeneca Pharma India Limited Financial Overview
AstraZeneca Pharma India Limited's market cap is currently ₹220.48B. The company's EPS TTM is ₹22.332; its P/E ratio is 120.24; and it has a dividend yield of 0.36%. AstraZeneca Pharma India Limited is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in INR
AstraZeneca Pharma India Limited Earnings and Revenue History
